RecombiMAb human IgG4 (S228P) isotype control, anti-respiratory syncytial virus

Clone Catalog # Category
Palivizumab-CP152 CP152
USD 235 - USD 6391

About RecombiMAb human IgG4 (S228P) isotype control, anti-respiratory syncytial virus

This human IgG4 S228P isotype control antibody reacts with respiratory syncytial virus and has low or no specific binding to any human sample.  The S228P mutation is included to prevent IgG4 Fab exchange. This is a recombinant human IgG4 antibody produced in CHO cells.

RecombiMAb human IgG4 (S228P) isotype control, anti-respiratory syncytial virus Specifications

IsotypeHuman IgG4, κ
FormulationPBS, pH 7.0 Contains no stabilizers or preservatives
Endotoxin
  • ≤0.5EU/mg (≤0.0005EU/μg)
  • Determined by LAL gel clotting assay
Aggregation<5% Determined by SEC
Purity
  • ≥95%
  • Determined by SDS-PAGE
Sterility0.2 μm filtration
ProductionPurified from CHO cell supernatant in an animal-free facility
PurificationProtein G
Molecular Weight150 kDa
StorageThe antibody solution should be stored at the stock concentration at 4°C. Do not freeze.

The Bio X Cell Singapore website will permanently redirect to https://bioxcell.com/ from 30th April 2026.

This transition is designed to streamline access to new products, product data, technical resources, and provide a smoother ordering experience through our unified global platform.

All products, documentation, and customer support will continue to be available at: https://bioxcell.com/

https://bxcell.sg/ will remain active temporarily to support this transition before redirecting automatically.

Please update your bookmarks to https://bioxcell.com/.

For regional support, please refer to https://bioxcell.com/our-distributors.

For Singapore customers, please contact our authorized distributor, Omnicell Pte Ltd:-

eMail : enquiry@omnicell.com.sg ; Tel : 67470201

Website : www.omnicell.com.sg 

Do not show this again [ CLOSE ]